Citadel Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-43,193
Closed -$164K 5615
2020
Q1
$164K Buy
+43,193
New +$164K ﹤0.01% 4161
2019
Q4
Sell
-17,198
Closed -$87K 5371
2019
Q3
$87K Buy
17,198
+1,042
+6% +$5.27K ﹤0.01% 4281
2019
Q2
$100K Sell
16,156
-458,146
-97% -$2.84M ﹤0.01% 4266
2019
Q1
$2.2M Sell
474,302
-1,104,258
-70% -$5.12M ﹤0.01% 2245
2018
Q4
$6.63M Sell
1,578,560
-60,424
-4% -$254K ﹤0.01% 1251
2018
Q3
$10.3M Buy
1,638,984
+1,502,039
+1,097% +$9.42M ﹤0.01% 1087
2018
Q2
$1.1M Buy
136,945
+32,256
+31% +$259K ﹤0.01% 2581
2018
Q1
$781K Buy
104,689
+34,242
+49% +$255K ﹤0.01% 2632
2017
Q4
$419K Buy
70,447
+47,130
+202% +$280K ﹤0.01% 2924
2017
Q3
$172K Sell
23,317
-27,808
-54% -$205K ﹤0.01% 3245
2017
Q2
$347K Sell
51,125
-80,126
-61% -$544K ﹤0.01% 2819
2017
Q1
$1.24M Buy
131,251
+111,547
+566% +$1.05M ﹤0.01% 1975
2016
Q4
$170K Sell
19,704
-99,012
-83% -$854K ﹤0.01% 3127
2016
Q3
$751K Buy
+118,716
New +$751K ﹤0.01% 2142
2016
Q2
Sell
-22,909
Closed -$100K 4129
2016
Q1
$100K Buy
+22,909
New +$100K ﹤0.01% 2883
2015
Q4
Sell
-88,594
Closed -$507K 4448
2015
Q3
$507K Buy
88,594
+17,269
+24% +$98.8K ﹤0.01% 2611
2015
Q2
$532K Buy
71,325
+32,950
+86% +$246K ﹤0.01% 2510
2015
Q1
$230K Sell
38,375
-119,254
-76% -$715K ﹤0.01% 3046
2014
Q4
$1.19M Buy
157,629
+126,468
+406% +$956K ﹤0.01% 2003
2014
Q3
$162K Buy
31,161
+24,031
+337% +$125K ﹤0.01% 2956
2014
Q2
$31K Sell
7,130
-9,595
-57% -$41.7K ﹤0.01% 3204
2014
Q1
$68K Sell
16,725
-79,392
-83% -$323K ﹤0.01% 3181
2013
Q4
$512K Sell
96,117
-58,430
-38% -$311K ﹤0.01% 2019
2013
Q3
$778K Sell
154,547
-242,707
-61% -$1.22M ﹤0.01% 1691
2013
Q2
$1.77M Buy
+397,254
New +$1.77M ﹤0.01% 1451